Literature DB >> 12677430

Genetic abnormalities and clinical classification of epidermolysis bullosa.

Yoshihiko Mitsuhashi1, Isao Hashimoto.   

Abstract

Genetic abnormalities for different subtypes of epidermolysis bullosa (EB) have been described. In dominant simplex type EB, mutations of the K5 or K14 gene lead to disruption of basal cells and the formation of bullae. The recessive simplex types include EB with muscular dystrophy due to abnormal plectin, EB without muscular dystrophy in patients homozygous for K14 gene abnormalities, and skin fragility syndrome, with formation of acantholytic vesicles within the epidermis due to PKP1 gene mutations. In junctional EB, mutations of the laminin 5, type XVII collagen, and alpha 6 beta 4 integrin genes have been reported. Dystrophic type EB is associated with various abnormalities of the type VII collagen gene. A new classification of EB based on these genetic abnormalities has been proposed. However, some concern has been voiced regarding the clinical utility of a classification based solely on genetic abnormalities. Although the reasons are unclear, identical genetic abnormalities have been known to be associated with different clinical features. A classification including a component based on clinical features would therefore be preferable. This article describes recently discovered genetic abnormalities and offers a new classification scheme for EB.

Entities:  

Mesh:

Year:  2003        PMID: 12677430     DOI: 10.1007/s00403-002-0369-0

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

Review 1.  Laminin isoforms in development and disease.

Authors:  Susanne Schéele; Alexander Nyström; Madeleine Durbeej; Jan F Talts; Marja Ekblom; Peter Ekblom
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 2.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

3.  A case of non-hallopeau-siemens recessive dystrophic epidermolysis bullosa.

Authors:  Gyo Shin Kang; Woo Tae Ko; Jae Hong Kim; Sung Min Choi; Ae Suk Kim; Dong Hoon Kim; Moo Kyu Suh
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

Review 4.  Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?

Authors:  Susanna Esposito; Sophie Guez; Francesca Manzoni; Annalisa Bosco; Donato Rigante
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

5.  Analysis of genes encoding laminin beta2 and related proteins in patients with Galloway-Mowat syndrome.

Authors:  Andreas Dietrich; Verena Matejas; Martin Bitzan; Seema Hashmi; Cathy Kiraly-Borri; Shuan-Pei Lin; Eva Mildenberger; Bernd Hoppe; Lars Palm; Takashi Shiihara; Jens-Oliver Steiss; Jeng-Daw Tsai; Udo Vester; Stefanie Weber; Elke Wühl; Kristina Zepf; Martin Zenker
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

6.  Cell adhesion to unnatural ligands mediated by a bifunctional protein.

Authors:  Juan Sánchez-Cortés; Katinka Bähr; Milan Mrksich
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

7.  Epidermolysis bullosa: a series of 12 patients in kashmir valley.

Authors:  Seema Qayoom; Qazi Masood; Javeed Sultan; Iffat Hassan; Majid Jehangir; Yasmeen J Bhat; Taseer Bhat; Muzamil Chisti
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

8.  Prevalence of anemia in patients with epidermolysis bullosa registered in Australia.

Authors:  Shelley Ji Eun Hwang; Benjamin S Daniel; Bonnie Fergie; Jessica Davey; Dédée F Murrell
Journal:  Int J Womens Dermatol       Date:  2015-02-18

9.  Inherited epidermolysis bullosa: clinical and therapeutic aspects.

Authors:  Vanessa Lys Simas Yamakawa Boeira; Erica Sales Souza; Bruno de Oliveira Rocha; Pedro Dantas Oliveira; Maria de Fátima Santos Paim de Oliveira; Vitória Regina Pedreira de Almeida Rêgo; Ivonise Follador
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

Review 10.  Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate.

Authors:  Elina Chermnykh; Ekaterina Kalabusheva; Ekaterina Vorotelyak
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.